Biotech · Private company
Vanquish Oncology, Inc.
Track this companyFree. Adds Vanquish Oncology, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PAC-1Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- PAC-1 CompoundPhase 1 · Glioblastoma MultiformeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal MelanomaPHASE1_PHASE2 · TERMINATED · started Jan 11, 2021ClinicalTrials.gov NCT04589832 · fetched Nov 12, 2026
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 2PHASE1 · TERMINATED · started Oct 1, 2017ClinicalTrials.gov NCT03332355 · fetched Nov 12, 2026
- Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1PHASE1 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02355535 · fetched Nov 12, 2026